These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32579501)

  • 41. Functional Neural Correlates of Anosognosia in Mild Cognitive Impairment and Alzheimer's Disease: a Systematic Review.
    Mondragón JD; Maurits NM; De Deyn PP
    Neuropsychol Rev; 2019 Jun; 29(2):139-165. PubMed ID: 31161466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease.
    Forouzannezhad P; Abbaspour A; Fang C; Cabrerizo M; Loewenstein D; Duara R; Adjouadi M
    J Neurosci Methods; 2019 Apr; 317():121-140. PubMed ID: 30593787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow.
    Beishon LC; Panerai RB; Budgeon C; Subramaniam H; Mukaetova-Ladinska E; Robinson TG; Haunton VJ
    J Alzheimers Dis; 2021; 80(4):1567-1581. PubMed ID: 33720895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis.
    Lin Y; Jiang WJ; Shan PY; Lu M; Wang T; Li RH; Zhang N; Ma L
    J Neurol Sci; 2019 Mar; 398():184-191. PubMed ID: 30735817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic Resonance Imaging Findings Among Individuals With Olfactory and Cognitive Impairment.
    Yi JS; Hura N; Roxbury CR; Lin SY
    Laryngoscope; 2022 Jan; 132(1):177-187. PubMed ID: 34383302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
    J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    Gerstenecker A; Hoagey DA; Marson DC; Kennedy KM
    J Alzheimers Dis; 2017; 60(2):537-547. PubMed ID: 28826185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A fuzzy-based system reveals Alzheimer's Disease onset in subjects with Mild Cognitive Impairment.
    Tangaro S; Fanizzi A; Amoroso N; Bellotti R;
    Phys Med; 2017 Jun; 38():36-44. PubMed ID: 28610695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.
    Park S; Pyo S; Shin SA; Lee JY; Kim YK; Park HJ; Youn JH; Park SW; Lee JY
    Psychiatry Res Neuroimaging; 2018 Oct; 280():30-38. PubMed ID: 30145383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment.
    Dang M; Yang C; Chen K; Lu P; Li H; Zhang Z;
    Alzheimers Res Ther; 2023 Feb; 15(1):27. PubMed ID: 36732782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    Gao Y; Sengupta A; Li M; Zu Z; Rogers BP; Anderson AW; Ding Z; Gore JC;
    PLoS One; 2020; 15(10):e0240513. PubMed ID: 33064765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia.
    Clare L; Woods RT; Moniz Cook ED; Orrell M; Spector A
    Cochrane Database Syst Rev; 2003; (4):CD003260. PubMed ID: 14583963
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.